Consonance Capital Management LP Iveric Bio, Inc. Transaction History

Consonance Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$5.08 - $6.89 $12.1 Million - $16.4 Million	-2,373,924 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.65 - $7.66 $8.31 Million - $11.3 Million	-1,471,070 Reduced 38.26%	2,373,924 $16.4 Million
Q3 2020 Nov 16, 2020	SELL	$4.01 - $6.29 $3.23 Million - $5.07 Million	-805,571 Reduced 17.32%	3,844,994 $21.7 Million
Q2 2020 Aug 14, 2020	BUY	$3.06 - $6.6 $4.59 Million - $9.9 Million	1,500,000 Added 47.61%	4,650,565 $23.7 Million
Q1 2020 May 15, 2020	SELL	$2.83 - $8.44 $780,514 - $2.33 Million	-275,800 Reduced 8.05%	3,150,565 $10.8 Million
Q4 2019 Feb 14, 2020	BUY	$0.93 - $8.58 $3.19 Million - $29.4 Million	3,426,365 New	3,426,365 $29.4 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.